These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15943844)

  • 1. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies.
    Seno H; Nakase H; Chiba T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
    Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
    Otaka M; Jin M; Odashima M; Matsuhashi T; Wada I; Horikawa Y; Komatsu K; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():42-6. PubMed ID: 15943846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
    Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
    Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
    Amarapurkar DN; Rane P
    J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
    Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of prokinetic treatment and eradication of Helicobacter pylori on gastric emptying and symptoms of functional dyspepsia].
    Radwan P; Grodzieński R; Zaorska-Rajca J; Skrzydło-Radomańska B; Słomka M; Wysokiński A
    Wiad Lek; 2001; 54(1-2):38-44. PubMed ID: 11344699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
    Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
    World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosapride in gastrointestinal disorders.
    Curran MP; Robinson DM
    Drugs; 2008; 68(7):981-91. PubMed ID: 18457463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
    Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ
    Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study.
    Hallerbäck BI; Bommelaer G; Bredberg E; Campbell M; Hellblom M; Lauritsen K; Wienbeck M; Holmgren LL
    Aliment Pharmacol Ther; 2002 May; 16(5):959-67. PubMed ID: 11966505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observation on transcutaneous electrical acupoint stimulation for treatment of functional dyspepsia].
    Zhou GY; Zhou GS; Jian-hong J
    Zhongguo Zhen Jiu; 2009 Jun; 29(6):436-40. PubMed ID: 19563187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tandospirone, a serotonin-1A agonist, on the hypothalamo-pituitary-gonadal axis of male patients.
    Kaneda Y; Fujii A
    Neuro Endocrinol Lett; 2001 Aug; 22(4):243-7. PubMed ID: 11524630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of mosapride on quality of life in functional dyspepsia].
    Cho YK; Choi MG; Kim SH; Lee IS; Kim SW; Chung IS; Lee SY; Choi SC; Seol SY
    Korean J Gastroenterol; 2004 Mar; 43(3):160-7. PubMed ID: 15034286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.